Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information.

导出 LinkOut

翻译打印收藏纠错

作者： Marina,Talamonti ^[1] ; Marco,Galluzzo ^[2]

作者单位： Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy. ^[1] Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. ^[2] Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy. ^[3]

DOI 10.21037/atm.2020.04.05

PMID 32953771

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of translational medicine

2020年8卷15期

971页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

检索历史清除